technology
Neuralink Receives Expanded FDA Approval for Commercial Brain-Computer Interface Deployment
The approval allows commercial deployment beyond the initial paralysis indication, opening the technology to a broader patient population and reigniting debates about cognitive enhancement.
David Park | Apr 18, 2026